Finance

Lists
6919:TPE
Caliway Biopharmaceuticals Co Ltd
77,20 NT$
-0,39%
(-0,30) 1D
12 ოქტ, 13:30:15 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6919...
Open
77,50 NT$
High
78,20 NT$
Low
77,00 NT$
Mkt. cap
120,22 მლრ.
Avg. vol.
8,54 მლნ.
Volume
2,23 მლნ.
52-wk high
188,00 NT$
52-wk low
75,10 NT$
EPS
-0,17 NT$
Open
77,50 NT$
High
78,20 NT$
Low
77,00 NT$
Mkt. cap
120,22 მლრ.
Avg. vol.
8,54 მლნ.
Volume
2,23 მლნ.
52-wk high
188,00 NT$
52-wk low
75,10 NT$
EPS
-0,17 NT$
News stories
From web sources and news partners
About Caliway Biopharmaceuticals Co Ltd
CEO-
Employees-
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitecaliwaybiopharma.com
Last report
11 აგვ. 2026
Fiscal period
Q2 2026
-0,14 NT$ / 2,93 NT$
-104,78%miss
Revenue / Est. (TWD)
3,57 მლნ. / 6,01 მლრდ.
-99,94%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
13,42 მლნ.
12,41 მლნ.
2,00 ათ.
3,57 მლნ.
Cost of goods sold
4,09 მლნ.
3,40 მლნ.
1,00 ათ.
1,24 მლნ.
Cost of revenue
4,09 მლნ.
3,40 მლნ.
1,00 ათ.
1,24 მლნ.
Research and development expenses
244,51 მლნ.
112,62 მლნ.
212,41 მლნ.
210,66 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-33,70 მლნ.
17,06 მლნ.
33,42 მლნ.
54,75 მლნ.
Operating expense
210,81 მლნ.
129,69 მლნ.
245,83 მლნ.
265,41 მლნ.
Total operating expenses
214,89 მლნ.
133,09 მლნ.
245,83 მლნ.
266,65 მლნ.
Operating income
-201,48 მლნ.
-120,68 მლნ.
-245,83 მლნ.
-263,08 მლნ.
Other non operating income
-280,00 ათ.
9,00 ათ.
-4,00 ათ.
-2,00 ათ.
EBT including unusual items
-7,73 მლნ.
80,19 მლნ.
-107,75 მლნ.
-222,52 მლნ.
EBT excluding unusual items
-7,73 მლნ.
80,19 მლნ.
-107,75 მლნ.
-222,52 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,73 მლნ.
80,19 მლნ.
-107,75 მლნ.
-222,52 მლნ.
Net profit margin
-57,62%
646,17%
-5 387 700,00%
-6 239,93%
Earnings per share
-0,01
0,05
-0,07
-0,14
Interest and investment income
59,73 მლნ.
85,42 მლნ.
78,51 მლნ.
82,27 მლნ.
Interest expense
-34,00 ათ.
-22,00 ათ.
-11,00 ათ.
-329,00 ათ.
Net interest expenses
59,70 მლნ.
85,40 მლნ.
78,50 მლნ.
81,94 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-195,81 მლნ.
-114,79 მლნ.
-239,81 მლნ.
-258,15 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები